Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001144204-19-035841

Chief Medical Officer acquired 12,200 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Mortensen Eric R. Chief Medical Officer 2019-07-22 Grant or award +12,200 145,612 D
Derivatives
Mortensen Eric R. Chief Medical Officer 2019-07-22 Grant or award · Stock Option (right to buy) +48,700 48,700 D
Loading xslF345X03/tv525807_4.xml…